An Open-label Drug-Drug Interaction Study in Healthy Female Subjects to Explore the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics and Safety of Single Doses of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Canagliflozin (Primary) ; Ethinylestradiol/levonorgestrel (Primary)
- Indications Obesity; Pregnancy; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Nov 2012 New trial record